Status:
COMPLETED
Treatment of Herpes Labialis by Photodynamic Therapy
Lead Sponsor:
University of Nove de Julho
Conditions:
Photodynamic Therapy
Herpes Simplex, Labial
Eligibility:
All Genders
12-60 years
Phase:
NA
Brief Summary
Lesions of herpes labialis are caused by the herpes simplex virus type 1 (HSV-1) and cause pain and aesthetic compromise. It is characterized by the formation of small vesicles that coalesce and ruptu...
Detailed Description
Lesions of herpes labialis are caused by the herpes simplex virus type 1 (HSV-1) and cause pain and aesthetic compromise. It is characterized by the formation of small vesicles that coalesce and ruptu...
Eligibility Criteria
Inclusion
- \- Patients of both sex,
- with no predilection for race or socioeconomic status,
- negative medical history
Exclusion
- Patients with a herpes infection in the dry desquamation stage will be excluded.
- Participants in continuous use of non-steroidal anti-inflammatory drugs and continued corticosteroid therapy for less than 1 week.
- Diabetic participants, smokers
- who need immunosuppressants,
- pregnant women and/or nursing mothers.
- HIV positive,
- hepatitis B or C.
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2023
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04037475
Start Date
January 1 2020
End Date
October 15 2023
Last Update
November 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anna Carolina R.T. Horliana
São Paulo, São Paulo, Brazil, 11030-480